Combined 18 F-FDG PET-CT and DCE-MRI to Assess Inflammation and Microvascularization in Atherosclerotic Plaques | Zendy

Martine T.B. Truijman | Zendy; Robert M. Kwee | Zendy; Raf H.M. van Hoof | Zendy; Evelien Hermeling | Zendy; Robert J. van Oostenbrugge | Zendy; Werner H. Mess | Zendy; Walter H. Backes | Zendy; Mat J.A.P. Daemen | Zendy; Jan Bucerius | Zendy; Joachim E. Wildberger | Zendy; M. Eline Kooi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Combined ¹⁸ F-FDG PET-CT and DCE-MRI to Assess Inflammation and Microvascularization in Atherosclerotic Plaques

Author(s) -

Martine T.B. Truijman,

Robert M. Kwee,

Raf H.M. van Hoof,

Evelien Hermeling,

Robert J. van Oostenbrugge,

Werner H. Mess,

Walter H. Backes,

Mat J.A.P. Daemen,

Jan Bucerius,

Joachim E. Wildberger,

M. Eline Kooi

Publication year - 2013

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.113.003140

Subject(s) - medicine , positron emission tomography , nuclear medicine , neovascularization , stenosis , rank correlation , magnetic resonance imaging , standardized uptake value , correlation , radiology , inflammation , positron emission , stroke (engine) , fluorodeoxyglucose , angiogenesis , mechanical engineering , geometry , mathematics , engineering , machine learning , computer science

Hallmarks of vulnerable atherosclerotic plaques are inflammation that can be assessed with 18fluorine-fluorodeoxyglucose positron emission tomography/computed tomography, and increased neovascularization that can be evaluated by dynamic contrast-enhanced-MRI. It remains unclear whether these parameters are correlated or represent independent imaging parameters. This study determines whether there is a correlation between inflammation and neovascularization in atherosclerotic carotid plaques.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research